Long-term and preventative treatment for seasonal affective disorder

CNS Drugs

Volumn 21, Issue 11, 2007, Pages 901-909

  Westrin, Åsa ^a   Lam, Raymond W ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Agomelatine, therapeutic use; Antidepressants, therapeutic use; Bupropion, therapeutic use; Citalopram, therapeutic use; Cognitive behavioural therapy; Disease prevention; Ginkgo biloba, therapeutic use; Maintenance therapy; Phototherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; GINKGO BILOBA EXTRACT; PLACEBO;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FLATULENCE; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; NAUSEA; PHOTOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEASONAL AFFECTIVE DISORDER; TREATMENT OUTCOME; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; PHOTOTHERAPY; PHYTOTHERAPY; SEASONAL AFFECTIVE DISORDER; TREATMENT OUTCOME;

EID: 35048845982     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721110-00003     Document Type: Review

References (46)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
2. Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984; 41 (1): 72-80
3. Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr 2005; 10 (8): 625-34
4. Blazer DG, Kessler RC, Swartz MS. Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. Br J Psychiatry 1998; 172: 164-7
5. Levitt AJ, Boyle MH, Joffe RT, et al. Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Can J Psychiatry 2000; 45 (7): 650-4
6. Levitt AJ, Boyle MH. The impact of latitude on the prevalence of seasonal depression. Can J Psychiatry 2002; 47 (4): 361-7
7. Sohn CH, Lam RW. Update on the biology of seasonal affective disorder. CNS Spectr 2005; 10 (8): 635-46
8. Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci 2000; 25 (5): 469-80
9. Schlager D, Froom J, Jaffe A. Winter depression and functional impairment among ambulatory primary care patients. Compr Psychiatry 1995; 36 (1): 18-24
10. Pendse BP, Ojehagen A, Engstrom G, et al. Social characteristics of seasonal affective disorder patients: comparison with suicide attempters with non-seasonal major depression and other mood disorder patients. Eur Psychiatry 2003; 18 (1): 36-9
11. Michalak EE, Wilkinson C, Hood K, et al. Seasonality, negative life events and social support in a community sample. Br J Psychiatry 2003; 182: 434-8
12. McElroy SL, Kotwal R, Malhotra S, et al. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 2004; 65 (5): 634-51
13. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005; 10 (8): 647-63
14. Pjrek E, Winkler D, Kasper S. Pharmacotherapy of seasonal affective disorder. CNS Spectr 2005; 10 (8): 664-9
15. Thompson C. Evidence-based treatment. In: Partonen T, Magnusson A, editors. Seasonal affective disorder: practice and research. New York; Oxford University Press, 2001: 151-8
16. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005; 162 (4): 656-62
17. Lam RW, Gorman CP, Michalon M, et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry 1995; 152 (12): 1765-70
18. Moscovitch A, Blashko CA, Eagles JM, et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology (Berl) 2004; 171 (4): 390-7
19. Hilger E, Willeit M, Praschak-Rieder N, et al. Reboxetine in seasonal affective disorder: an open trial. Eur Neuropsychopharmacol 2001; 11 (1): 1-5
20. Lingjaerde O, Reichborn-Kjennerud T, Haggag A, et al. Treatment of winter depression in Norway: II. A comparison of the selective monoamine oxidase A inhibitor moclobemide and placebo. Acta Psychiatr Scand 1993; 88: 372-80
21. Dilsaver SC, Qamar AB, Del Medico VJ. The efficacy of bupropion in winter depression: results of an open trial. J Clin Psychiatry 1992; 53: 252-5
22. Partonen T, Lonnqvist J. Moclobemide and fluoxetine in treatment of seasonal affective disorder. J Affect Disord 1996; 41 (2): 93-9
23. Lam RW, Levitt AJ, Levitan RD, et al. The Can-SAD Study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 2006; 163 (5): 805-12
24. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851-5
25. Parikh SV, Lam RW. Clinical guidelines for the treatment of depressive disorders: I. Definitions, prevalence, and health burden. Can J Psychiatry 2001; 46 Suppl. 1: 13-20S
26. Kennedy SH, Lam RW, Cohen NL, et al. Clinical guidelines for the treatment of depressive disorders: IV. Medications and other biological treatments. Can J Psychiatry 2001; 46 Suppl. 1: 38-58S
27. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 (4 Suppl.): 1-45
28. Bauer M, Whybrow PC, Angst J, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders (Pt 1): acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002; 3: 5-43
29. Pjrek E, Winkler D, Konstantinidis A, et al. Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl) 2006; 190 (4): 575-9
30. Terman M, Terman JS, Quitkin FM, et al. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology 1989; 2 (1): 1-22
31. Lam RW, Levitt AJ, editors. Canadian consensus guidelines for the treatment of seasonal affective disorder. Vancouver (BC); Clinical and Academic Publishing, 1999 [online]. Available from URL: http://www.ubcsad.ca [Accessed 2007 Jul 24]
32. Thorell LH, Kjellman B, Arned M, et al. Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up. Int Clin Psychopharmacol 1999; 14 Suppl. 2: S7-11
33. Martiny K, Lunde M, Simonsen C, et al. Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy: a placebo-controlled study. Acta Psychiatr Scand 2004; 109 (3): 230-4
34. Leonhardt G, Wirz-Justice A, Krauchi K, et al. Long-term follow-up of depression in seasonal affective disorder. Compr Psychiatry 1994; 35 (6): 457-64
35. Sakamoto K, Nakadaira S, Kamo K, et al. A longitudinal follow-up study of seasonal affective disorder. Am J Psychiatry 1995; 152 (6): 862-8
36. Thompson C, Raheja SK, King EA. A follow-up study of seasonal affective disorder. Br J Psychiatry 1995; 167 (3): 380-4
37. Graw P, Gisin B, Wirz-Justice A. Follow-up study of seasonal affective disorder in Switzerland. Psychopathology 1997; 30 (4): 208-14
38. Meesters Y, Jansen JH, Beersma DG, et al. Early light treatment can prevent an emerging winter depression from developing into a full-blown depression. J Affect Disord 1993; 29 (1): 41-7
39. Terman JS, Terman M, Amira L. One-week light treatment of winter depression near its onset: the time course of relapse. Depression 1994; 2: 20-31
40. Meesters Y, Jansen JH, Beersma DG, et al. An attempt to prevent winter depression by light exposure at the end of September. Biol Psychiatry 1994; 35 (4): 284-6
41. Partonen T, Lonnqvist J. Prevention of winter seasonal affective disorder by bright-light treatment. Psychol Med 1996; 26 (5): 1075-80
42. Meesters Y, Beersma DG, Bouhuys AL, et al. Prophylactic treatment of seasonal affective disorder (SAD) by using light visors: bright white or infrared light? Biol Psychiatry 1999; 46 (2): 239-46
43. Modell JG, Rosenthal NE, Harriett AE, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry 2005; 58 (8): 658-67
44. Lingaerde O, Foreland AR, Magnusson A. Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial. Acta Psychiatr Scand 1999; 100 (1): 62-6
45. Rohan KJ, Lindsey KT, Roecklein KA, et al. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J Affect Disord 2004; 80 (2-3): 273-83
46. Pjrek E, Winkler D, Stastny J, et al. Bright light therapy in seasonal affective disorder: does it suffice? Eur Neuropsychopharmacol 2004; 14 (4): 347-51